title: Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.
abstract: BACKGROUND
  Steroid Responsive Meningitis-Arteritis (SRMA) is a common cause of inflammation of the canine central nervous system (CNS). To investigate if transforming growth factor beta 1 (TGF-β1), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) are involved in the production of excessive immunoglobulin A (IgA), the induction of acute phase proteins and in the development of a systemic necrotizing vasculitis, characteristic of SRMA, these three signalling proteins were evaluated.
  
  
  RESULTS
  Cerebrospinal fluid (CSF) and serum samples of dogs during the acute phase of SRMA (SRMA) were tested for IL-6, VEGF and TGF- β1. Results were compared to those of dogs affected with SRMA during treatment (SRMA Th) and during relapse (SRMA R), to dogs with other meningoencephalomyelitides (ME), with miscellaneous non-inflammatory diseases of the CNS (CNS-Mix), with idiopathic epilepsy (IE), with systemic inflammatory diseases (Syst. Infl.) and with healthy dogs (Healthy). Concentrations of IL-6 and VEGF in CSF were significantly elevated in the SRMA group compared to the other disease categories (p<0.05). The CSF concentrations of TGF-β1 were increased in SRMA group, but statistically significant differences were found only in comparison with Healthy and CNS-Mix groups. No differences were detected in the serum concentrations of TGF-β1 between the different groups. In untreated SRMA patients, a positive correlation (rSpear = 0.3549; P=0.0337) between concentrations of TGF-β1 and IgA concentration was found in CSF, while concentrations of IL-6 and VEGF in CSF positively correlated with the degree of pleocytosis (rSpear=0.8323; P<0.0001 and rSpear=0.5711; P=0.0166, respectively).
  
  
  CONCLUSIONS
  Our results suggest that these three signalling proteins are biomarkers of disease activity in SRMA. VEGF might play an important role in the development of a systemic arteritis. TGF-β1 is considered to be involved in the excessive IgA production, while IL-6 in the pleocytosis. The combined intrathecal increase of TGF-β1 and IL-6 detected in SRMA could possibly force CD4 progenitors to differentiate towards the newly described Th17 lymphocyte subset and enhance the autoimmune response.
authors: Department of Small Animal Medicine and Surgery, University of Veterinary Medicine, Hannover, Germany. arianna.maiolini@tiho-hannover.de
authors: Arianna
authors: A
authors: Maiolini
authors: Meike
authors: M
authors: Otten
authors: Marion
authors: M
authors: Hewicker-Trautwein
authors: Regina
authors: R
authors: Carlson
authors: Andrea
authors: A
authors: Tipold
mesh_terms: D000209:Acute-Phase Proteins / Q000502:physiology; D000818:Animals; D001167:Arteritis / Q000097:blood / Q000134:cerebrospinal fluid / Q000503:physiopathology / Q000662:veterinary*; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D004283:Dog Diseases / Q000097:blood / Q000134:cerebrospinal fluid / Q000503:physiopathology*; D004285:Dogs; D007070:Immunoglobulin A / Q000097:blood; D007249:Inflammation / Q000097:blood / Q000134:cerebrospinal fluid / Q000503:physiopathology / Q000662:veterinary; D015850:Interleukin-6 / Q000097:blood / Q000134:cerebrospinal fluid / Q000502:physiology*; D008581:Meningitis / Q000097:blood / Q000134:cerebrospinal fluid / Q000503:physiopathology / Q000662:veterinary*; D053773:Transforming Growth Factor beta1 / Q000097:blood / Q000134:cerebrospinal fluid / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000134:cerebrospinal fluid / Q000502:physiology*
chemical_list: D000209:Acute-Phase Proteins; D015415:Biomarkers; D007070:Immunoglobulin A; D015850:Interleukin-6; D053773:Transforming Growth Factor beta1; D042461:Vascular Endothelial Growth Factor A
references: J Vet Intern Med. 1988 Jan-Mar;2(1):26-35
references: 3065492
references: J Neuroimmunol. 1995 Aug;61(1):71-8
references: 7560015
references: Zentralbl Veterinarmed A. 1999 Mar;46(2):75-85
references: 10216444
references: J Small Anim Pract. 2006 Jul;47(7):370-6
references: 16842272
references: J Leukoc Biol. 1994 May;55(5):662-75
references: 8182345
references: J Pediatr. 1992 Dec;121(6):924-6
references: 1447658
references: Pediatr Res. 2004 Dec;56(6):953-9
references: 15470196
references: Vet J. 2012 Feb;191(2):219-24
references: 21277241
references: Vet Clin North Am Small Anim Pract. 1996 Jul;26(4):857-74
references: 8813754
references: Eur J Immunol. 1987 Oct;17(10):1411-6
references: 3500054
references: Vet Immunol Immunopathol. 2008 Oct 15;125(3-4):274-83
references: 18619679
references: Immunity. 2004 Oct;21(4):467-76
references: 15485625
references: Vet Immunol Immunopathol. 1994 Aug;42(2):149-59
references: 7975187
references: Nat Immunol. 2005 Nov;6(11):1123-32
references: 16200070
references: Nature. 2006 May 11;441(7090):235-8
references: 16648838
references: Scand J Rheumatol. 1997;26(4):314-7
references: 9310113
references: Vet J. 2011 Feb;187(2):260-6
references: 20117950
references: J Vet Intern Med. 2009 Jul-Aug;23(4):862-70
references: 19566851
references: Can Vet J. 2010 Oct;51(10):1109-14
references: 21197202
references: Nat Immunol. 2005 Nov;6(11):1133-41
references: 16200068
references: Clin Immunol Immunopathol. 1996 Aug;80(2):155-61
references: 8764560
references: J Neuroimmunol. 1998 Aug 14;89(1-2):182-90
references: 9726841
references: Yonsei Med J. 1992 Jun;33(2):183-8
references: 1413896
references: Arthritis Rheum. 2011 Dec;63(12):3988-97
references: 21953143
references: J Immunol. 2001 Jul 15;167(2):1004-13
references: 11441109
references: Trends Immunol. 2003 Jan;24(1):25-9
references: 12495721
references: Am J Physiol. 1990 Jul;259(1 Pt 2):R126-32
references: 2197879
references: Trends Mol Med. 2011 Jul;17(7):347-62
references: 21481637
references: Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):201-14
references: 10507305
references: Lancet. 2004 Aug 7-13;364(9433):533-44
references: 15302199
references: J Vet Intern Med. 1995 Sep-Oct;9(5):304-14
references: 8531175
references: Curr Opin Immunol. 2007 Dec;19(6):652-7
references: 17766098
references: Am J Cardiol. 1999 Feb 1;83(3):337-9
references: 10072219
references: J Small Anim Pract. 2000 Jul;41(7):295-301
references: 10976624
references: Angiogenesis. 2008;11(2):109-19
references: 18293091
references: J Vet Emerg Crit Care (San Antonio). 2009 Oct;19(5):459-66
references: 19821887
references: J Vet Intern Med. 2001 Mar-Apr;15(2):131-5
references: 11300596
references: Perspect Biol Med. 1991 Autumn;35(1):68-73
references: 1780217
references: Gene. 1995 Apr 3;155(2):307-8
references: 7721110
references: Circulation. 2002 Feb 12;105(6):766-9
references: 11839635
references: Vet Clin Pathol. 2007 Sep;36(3):253-60
references: 17806073
references: Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):198-206
references: 19733404
references: Vet J. 2009 Oct;182(1):125-30
references: 18590973
references: Arthritis Res. 2002;4 Suppl 3:S233-42
references: 12110143
references: Am J Pathol. 1995 May;146(5):1029-39
references: 7538264
references: Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):248-55
references: 18760844
references: Cancer Biother Radiopharm. 2005 Dec;20(6):648-61
references: 16398617
references: Clin Immunol Immunopathol. 1995 Oct;77(1):107-10
references: 7554474
references: J Vet Intern Med. 2008 Sep-Oct;22(5):1149-56
references: 18691368
references: Res Vet Sci. 1995 Mar;58(2):103-8
references: 7761686